Conference abstract · 28 May 2018
Conference abstractPublished 18 Aug 2016
Molecular basis of acute myeloid leukemia
Queen’s University Belfast, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The advancement of next generation sequencing has identified a spectrum of mutations that contribute to the different types of blood cancers. These mutations can be used for the diagnostic classification and monitoring but in acute myeloid leukemia (AML) and with the exception of acute promyelocytic leukemia (APL); have not resulted in the development of novel targeted therapies. In this keynote presentation, the author will explore the range of mutations and their interactions, examine some of the molecular consequences of these and potentially how the epigenetic therapies may be useful across the different sub-types.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 30 Aug 2017
Study of Alternative Wilms tumor gene methylation as an epigenetic biomarker in acute myeloid Leukemia
Conference abstract · 15 Jun 2017
Integrated genetic and epigenetic analysis identifies biomarkers of prognostic significance in pediatric acute myeloid leukemia
Conference abstract · 5 Dec 2016
Estimation of stem cell frequency in acute myeloid leukemia at diagnosis: Relation to hematological and clinical parameters
Conference abstract · 1 Sep 2015
Clinical significance of cytogenetic biomarkers in acute myeloid leukemia: An Indian experience
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- SubjectHaematology
- BylineArticles whose byline prints “Ken Mills”
